Trials / Conditions / Myxoid/Round Cell Liposarcoma
Myxoid/Round Cell Liposarcoma
6 registered clinical trials studyying Myxoid/Round Cell Liposarcoma — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1 NCT06083883 | M.D. Anderson Cancer Center | Phase 1 |
| Active Not Recruiting | BOXR1030 T Cells in Subjects With Advanced GPC3-Positive Solid Tumors NCT05120271 | Sotio Biotech Inc. | Phase 1 / Phase 2 |
| Terminated | NY-ESO-1-redirected CRISPR (TCRendo and PD1) Edited T Cells (NYCE T Cells) NCT03399448 | University of Pennsylvania | Phase 1 |
| Active Not Recruiting | MAGE-A4ᶜ¹º³²T for Multi-Tumor NCT03132922 | Adaptimmune | Phase 1 |
| Terminated | Study to Compare the Safety and Efficacy of CMB305 With Atezolizumab to Atezolizumab Alone in Participants Wit NCT02609984 | Immune Design, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 2 |
| Withdrawn | NY-ESO-1 Specific T Cells After Cyclophosphamide in Treating Patients With Advanced Synovial Sarcoma or Myxoid NCT02059850 | Fred Hutchinson Cancer Center | Phase 1 |